Syneron Medical Ltd. announced the FDA granted 510K marketing clearance to its Polaris LV system for vascular lesion treatment.
Derm In The News: February 25-March 2
ReV Up Your Vitiligo Treatment Strategies
Pointers With Portela: Dangerous Skin Care Marketing
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
Suicide Risk in Isotretinoin Users: New Data
Johnson & Johnson Innovative Medicine Sponsorship Expands GW Teledermatology Program
2 Commerce Drive Cranbury, NJ 08512